company background image
600572 logo

Zhejiang CONBA PharmaceuticalLtd SHSE:600572 Stock Report

Last Price

CN¥4.94

Market Cap

CN¥12.6b

7D

0.2%

1Y

-28.6%

Updated

30 Apr, 2024

Data

Company Financials +

Zhejiang CONBA Pharmaceutical Co.,Ltd.

SHSE:600572 Stock Report

Market Cap: CN¥12.6b

600572 Stock Overview

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research and development, manufacturing, and sales of medicines and general health products in China.

600572 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends4/6

Zhejiang CONBA Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang CONBA PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥4.94
52 Week HighCN¥7.44
52 Week LowCN¥4.07
Beta0.46
1 Month Change2.28%
3 Month Change10.51%
1 Year Change-28.61%
3 Year Change12.53%
5 Year Change-36.59%
Change since IPO210.19%

Recent News & Updates

Recent updates

Shareholder Returns

600572CN PharmaceuticalsCN Market
7D0.2%6.1%4.4%
1Y-28.6%-11.9%-12.6%

Return vs Industry: 600572 underperformed the CN Pharmaceuticals industry which returned -11.9% over the past year.

Return vs Market: 600572 underperformed the CN Market which returned -12.6% over the past year.

Price Volatility

Is 600572's price volatile compared to industry and market?
600572 volatility
600572 Average Weekly Movement3.4%
Pharmaceuticals Industry Average Movement7.7%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 600572 has not had significant price volatility in the past 3 months.

Volatility Over Time: 600572's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19938,411Guoliang Luowww.conbagroup.com

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research and development, manufacturing, and sales of medicines and general health products in China. It offers Chinese herbal decoction pieces, Chinese patent medicines, chemical pharmaceutical products, chemical raw materials, medical devices, and biological products.

Zhejiang CONBA Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Zhejiang CONBA PharmaceuticalLtd's earnings and revenue compare to its market cap?
600572 fundamental statistics
Market capCN¥12.64b
Earnings (TTM)CN¥523.43m
Revenue (TTM)CN¥6.43b

24.3x

P/E Ratio

2.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600572 income statement (TTM)
RevenueCN¥6.43b
Cost of RevenueCN¥2.89b
Gross ProfitCN¥3.54b
Other ExpensesCN¥3.02b
EarningsCN¥523.43m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.20
Gross Margin55.08%
Net Profit Margin8.14%
Debt/Equity Ratio14.2%

How did 600572 perform over the long term?

See historical performance and comparison

Dividends

4.0%

Current Dividend Yield

98%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.